Search

everythinglearnresearchcommunity

for

Search:↓

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Oral minoxidil effectively improves hair regrowth in cancer survivors with late alopecia.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Bioengineered microneedles and nanomedicine offer promising, precise treatments for tissue regeneration.

Clinicians should understand tattoos to manage health issues, as tattoos can cause complications and affect medical assessments.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

Cancer treatments often cause skin, nail, and hair problems.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Epidermal stem cells show promise for future dermatology treatments due to ongoing advancements.

A new microneedle system may improve hair loss treatment by delivering ketoconazole directly to hair follicles.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

Hair loss is a common side effect of hormone treatments for cancer.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Genes play a significant role in male-pattern baldness, and understanding them could lead to new treatments and insights into related health issues.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Ozone therapy might improve cancer treatment and reduce its side effects.

Spironolactone is effective and safe for treating acne with minimal side effects.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Rosemary may help treat various skin conditions due to its antioxidant and anti-inflammatory properties.

Caffeine may benefit skin and hair health but more research is needed to confirm its effectiveness in dermatology.